Biomarin Pharmaceutical (BMRN): Most Undervalued Stocks to Buy and Hold for 2 Years

11 hours ago 3

Maham Fatima

Mon, June 8, 2026 astatine 5:47 AM CDT 2 min read

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is 1 of the most undervalued stocks to bargain and clasp for 2 years. On May 4, BioMarin reported fiscal results for Q1 2026, with full revenues reaching $766 million. Driven by the caller acquisition of Amicus Therapeutics and the summation of GALAFOLD and POMBILITI + OPFOLDA to its portfolio, the institution has accrued its full-year 2026 gross guidance to a scope of $3.825 to $3.925 billion, representing a year-over-year maturation complaint of 20%.

The institution highlighted important advancement crossed its objective pipeline and commercialized operations. Key updates included the FDA support of PALYNZIQ for adolescents with phenylketonuria, the submission of an sNDA for the afloat support of VOXZOGO for achondroplasia, and affirmative objective information presentations for BMN 351 and VOXZOGO. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) besides reported dependable gross maturation crossed its existing enzyme therapy products and a accordant summation successful the fig of children treated with VOXZOGO.

Most Undervalued Stocks to Buy and Hold for 2 Years

To enactment its maturation strategy, BioMarin secured ~$3.7 cardinal successful non-convertible indebtedness to money the Amicus acquisition portion maintaining beardown operating currency flows of $221 cardinal for the quarter. With full currency reserves of ~$2 cardinal and upcoming Phase 3 information readouts expected aboriginal this year, the institution remains focused connected scaling its commercialized portfolio and advancing its innovation pipeline to thrust semipermanent worth for patients and shareholders.

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) develops and commercializes therapies for superior and life-threatening aesculapian conditions and uncommon diseases.

While we admit the imaginable of BMRN arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article